T. Rowe Price Global Value Equity Fund (TRGVX) is an open-end mutual fund that seeks long-term capital appreciation by investing primarily in equity securities of companies throughout the world that exhibit value characteristics and favorable prospects for capital appreciation; it normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in such common stocks of undervalued companies, with a diversified portfolio of 80-100 holdings across sectors including financials, technology, healthcare, and materials, as well as flexibility to include emerging markets and smaller companies. The fund benchmarks its performance against the MSCI World Value Index Net and MSCI World Index Net, employs a bottom-up research-driven process led by portfolio manager Sebastien Mallet (managing since the fund's inception on November 28, 2012), supported by associate portfolio manager Marta Yago (appointed October 2023) and T. Rowe Price's global team of over 170 research professionals across 17 offices worldwide. As of late 2025, the fund manages approximately USD 160 million in assets with a net expense ratio of 0.89%, 70% annual portfolio turnover, and recent holdings adjustments including additions of Berkshire Hathaway, Admiral Group, Banco do Brasil, and Tencent, alongside sales of Elevance Health, Thermo Fisher Scientific, and Nintendo. The fund operates globally, investing in at least five countries including the U.S., with allocations driven by stock selection rather than top-down country bets, targeting long-term investors tolerant of international and value-style risks such as market volatility, currency fluctuations, and potential underperformance during growth-favored periods. Managed by T. Rowe Price Group, Inc., founded in 1937 and headquartered in Baltimore, Maryland, the fund benefits from the parent's recent strategic expansions including a September 2025 partnership with Goldman Sachs Asset Management involving up to $1 billion investment in T. Rowe stock and joint private-market product offerings for retail and retirement investors, as well as a February 2025 alliance with insurer Aspida (backed by Ares Management) to manage public and private assets and develop tailored insurance solutions.